Astrana Health Inc · Q4 2019 earnings

Briefing

Apollo Medical Holdings, Inc. reported improved financial performance in Q4 2019, marked by revenue growth and increased net income.

ApolloMed reported a strong Q4 2019 with a 68% increase in total revenue to $178.8 million and a net income of $6.7 million, driven by recent acquisitions and preferred dividends. The company manages over one million lives and is focused on scalable and profitable growth.

• Total revenue increased by 68% to $178.8 million.
• Capitation revenue increased by 92% to $148.6 million, representing 83% of total revenue.
• Net income attributable to Apollo Medical Holdings, Inc. was $6.7 million, compared to a net loss of $3.1 million in the same quarter of the previous year.
• The company entered into a new management services agreement effective January 1, 2020, covering approximately 145,000 members in Southern California.

Headline financials

Revenue & EPS history

For the year ending December 31, 2020, ApolloMed expects total revenue between $665.0 million and $675.0 million, net income between $20.0 million and $30.0 million, EBITDA between $55.0 million and $67.0 million, and Adjusted EBITDA between $75.0 million and $90.0 million.